Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

cbdMD stock price, quote, forecast and news

YCBD
US12482W1018
A2PJM3

Price

0.56
Today +/-
-0.01
Today %
-1.40 %
P

cbdMD stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the cbdMD stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the cbdMD stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the cbdMD stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze cbdMD's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

cbdMD Stock Price History

DatecbdMD Price
9/9/20240.56 undefined
9/6/20240.57 undefined
9/5/20240.55 undefined
9/4/20240.54 undefined
9/3/20240.57 undefined
8/30/20240.54 undefined
8/29/20240.54 undefined
8/28/20240.52 undefined
8/27/20240.55 undefined
8/26/20240.55 undefined
8/23/20240.53 undefined
8/22/20240.55 undefined
8/21/20240.55 undefined
8/20/20240.55 undefined
8/19/20240.49 undefined
8/16/20240.47 undefined
8/15/20240.49 undefined
8/14/20240.49 undefined
8/13/20240.48 undefined
8/12/20240.50 undefined

cbdMD Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into cbdMD, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by cbdMD from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects cbdMD’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of cbdMD. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into cbdMD’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing cbdMD’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on cbdMD’s growth potential.

cbdMD Revenue, EBIT and net profit per share

DatecbdMD RevenuecbdMD EBITcbdMD Net Income
2026e79.18 M undefined36.24 M undefined4.49 M undefined
2025e22.02 M undefined-1.08 M undefined-59.5 M undefined
2024e20.13 M undefined-4.29 M undefined-175.84 M undefined
202324.16 M undefined-9.27 M undefined-26.94 M undefined
202235.4 M undefined-17.31 M undefined-74.09 M undefined
202144.48 M undefined-19.62 M undefined-25.95 M undefined
202041.88 M undefined-17.58 M undefined12.24 M undefined
201923.65 M undefined-14.36 M undefined-50.43 M undefined
2018460,000 undefined-1.8 M undefined-410,000 undefined
20174.47 M undefined-240,000 undefined-1.74 M undefined
20162.03 M undefined-3.73 M undefined-3.36 M undefined
201510,000 undefined-1.3 M undefined-1.13 M undefined

cbdMD Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e2026e
02402341443524202279
--100.00--78.267.32-20.45-31.43-16.6710.00259.09
--75.00-60.8763.4165.9162.8658.33---
00301426292214000
-1-30-1-14-17-19-17-9-4-136
--150.00---60.87-41.46-43.18-48.57-37.50-20.00-4.5545.57
-1-3-10-5012-25-74-26-175-594
-200.00-66.67---124.00-308.33196.00-64.86573.08-66.29-106.78
0.170.170.10.170.411.221.332.02000
------------
Details

Keystats

ⓘ

Revenue and Growth

The cbdMD Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the cbdMD is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201520162017201820192020202120222023
                 
0.501.16.55.515.127.47.71.8
00.20.91.81.90.91.11.41.22
000.52.40.20000
0.20.70.60.14.34.654.34.05
0.50.10.60.93.93.12.92.61
1.213.711.715.823.736.4168.07
0.10.20.10.11.7108.25.34.07
00000001.40.7
000000000
0.50.53.23.221.621.62317.83.22
000054.754.756.700
0000800800500200138.71
0.60.73.33.378.887.188.424.78.13
1.81.771594.6110.8124.840.716.2
                 
000001001001007.96
2.54.810.521.897.2126.5176.4178.8183.39
-1.1-4.5-6.3-6.7-59.6-47.4-73.3-147.4-174.36
000-2.5100000
000-2.500000
1.40.34.210.0937.679.2103.231.59.03
0.10.20.50.532.9321.91
0.10.910.30.73.93.93.22.76
1000020000000
2008000000000
0000090010002.49
0.51.91.513.77.775.24.67
0000060001000.01
00002.20.9000
000.405122.514.842.49
000.4053.22414.84.12.49
0.51.91.9156.931.721.89.37.16
1.92.26.111.0994.5110.912540.816.2
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of cbdMD provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand cbdMD's financial health and stability.

Assets

cbdMD's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that cbdMD must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of cbdMD after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into cbdMD's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
-1-3-10-5112-23-70-22
0000001,0001,0001,000
0000-2-1000
00-1,000-4,00001,000-1,000-2,0000
000-138-24115616
000000000
000000000
-1-2-2-5-15-10-14-14-4
0000-1-1000
0000-2-1-200
000000-2,00001,000
000000000
001,000001,000000
2101019213002
22210172228-4-1
-----1.00----
000000-2-4-3
000401011-19-4
-1.97-3.03-2.34-5.95-16.63-11.98-14.43-15.66-4.6
000000000

cbdMD stock margins

The cbdMD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of cbdMD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for cbdMD.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the cbdMD's sales revenue. A higher gross margin percentage indicates that the cbdMD retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the cbdMD's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the cbdMD's total revenue generated. When comparing the revenue margin year over year, investors can gauge the cbdMD's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the cbdMD. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the cbdMD's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

cbdMD Margin History

cbdMD Gross margincbdMD Profit margincbdMD EBIT margincbdMD Profit margin
2026e62.01 %45.77 %5.67 %
2025e62.01 %-4.91 %-270.29 %
2024e62.01 %-21.34 %-873.64 %
202362.01 %-38.37 %-111.53 %
202263.11 %-48.9 %-209.29 %
202167.42 %-44.11 %-58.34 %
202062.97 %-41.98 %29.23 %
201961.35 %-60.72 %-213.23 %
201878.26 %-391.3 %-89.13 %
201769.8 %-5.37 %-38.93 %
201620.2 %-183.74 %-165.52 %
201562.01 %-13,000 %-11,300 %

cbdMD Stock Sales Revenue, EBIT, Earnings per Share

The cbdMD earnings per share therefore indicates how much revenue cbdMD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue cbdMD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates cbdMD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of cbdMD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating cbdMD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

cbdMD Revenue, EBIT and net profit per share

DatecbdMD Sales per SharecbdMD EBIT per sharecbdMD Earnings per Share
2026e1.21 undefined0 undefined0.07 undefined
2025e0.34 undefined0 undefined-0.91 undefined
2024e0.31 undefined0 undefined-2.68 undefined
202311.94 undefined-4.58 undefined-13.32 undefined
202226.62 undefined-13.02 undefined-55.71 undefined
202136.46 undefined-16.08 undefined-21.27 undefined
202041.88 undefined-17.58 undefined12.24 undefined
201959.13 undefined-35.9 undefined-126.08 undefined
20182.71 undefined-10.59 undefined-2.41 undefined
201744.7 undefined-2.4 undefined-17.4 undefined
201611.94 undefined-21.94 undefined-19.76 undefined
20150.06 undefined-7.65 undefined-6.65 undefined

cbdMD business model

CBDMD Inc. was founded in 2015 and is based in Charlotte, North Carolina. It is a leading company in the manufacturing and marketing of high-quality CBD products, and has quickly gained recognition and a strong reputation in the industry. The company's business model is centered around a clear mission: to offer high-quality CBD solutions that improve people's lives. cbdMD Inc. not only strives to produce products of the highest quality, but also aims to spread information about the benefits of CBD. The goal is to raise awareness among people that CBD is a natural way to alleviate stress, anxiety, pain, and other ailments. The company offers a wide range of CBD products, including oils, tinctures, capsules, gummies, topicals, bath additives, pet products, and more. cbdMD Inc. manufactures its products from pure natural ingredients and they are THC-free, meaning they have no psychoactive effects. The company operates in various sectors, including the sports segment, where it focuses on meeting the needs of athletes. cbdMD Inc. is dedicated to developing products that promote muscle recovery, alleviate pain, and improve focus. In the pet treatments segment, cbdMD Inc. offers a wide range of products specially tailored for the needs of pets. The products range from CBD oils and treats to bath balms and creams. The company places special emphasis on quality to ensure that it is also a gentle treatment method. cbdMD Inc. has placed its products in retail stores such as CVS and CBD Shops, and also collaborates with other online platforms. However, the core business of cbdMD Inc. is the manufacturing and sale of CBD oils. These oils are available in different sizes and concentrations. The oil blends, which are primarily plant-based, are gluten-free and sugar-free. They are rich in cannabinoids, contain hemp oil with omega-3, -6, and -9 fatty acids, and thus offer valuable health and wellness as a dietary supplement. In conclusion, cbdMD Inc. has a clear vision of producing high-quality products and spreading information about the benefits of CBD. With its wide range of CBD products and consistent focus on customer needs, the company has quickly gained recognition in the industry. Through an environmentally responsible value chain and transparent communication with its customers, cbdMD Inc. promotes awareness of natural dietary supplements and health care. cbdMD is one of the most popular companies on Eulerpool.com.

cbdMD SWOT Analysis

Strengths

cbdMD Inc has a strong brand presence in the CBD industry, which helps to build customer loyalty and trust. The company offers a wide range of high-quality CBD products, including oils, capsules, and topicals, catering to various customer preferences. cbdMD Inc has established strategic partnerships and collaborations, allowing for market expansion and increased distribution channels. The company has implemented effective marketing strategies to reach a wider audience and create awareness about the benefits of CBD.

Weaknesses

One of the weaknesses of cbdMD Inc is its dependency on third-party suppliers for sourcing raw materials. This can result in potential supply chain disruptions and quality control challenges. The company faces competition from both established players and new entrants in the CBD market, which may impact market share and pricing. cbdMD Inc may need to invest in research and development to continuously innovate and stay ahead of evolving customer needs and preferences.

Opportunities

The legalization of CBD in more countries and states presents a significant growth opportunity for cbdMD Inc. The company can explore new markets and expand its customer base globally. The increasing acceptance of CBD as a natural remedy and wellness product opens avenues for cbdMD Inc to educate consumers and penetrate new market segments. The company can also leverage the growing e-commerce trend to enhance online sales and reach customers directly.

Threats

Regulatory uncertainty and evolving legislation regarding the sale and usage of CBD products pose a potential threat to cbdMD Inc. Changes in regulations can impact the company's operations and market access. The CBD industry is characterized by intense competition, making it crucial for cbdMD Inc to differentiate itself and maintain competitive pricing. Counterfeit products and low-quality imitations can tarnish the company's reputation and affect customer trust.

cbdMD Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

cbdMD historical P/E ratio, EBIT, and P/S ratio.

cbdMD shares outstanding

The number of shares was cbdMD in 2023 — This indicates how many shares 2.022 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue cbdMD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates cbdMD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of cbdMD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating cbdMD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

cbdMD Stock splits

In cbdMD's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for cbdMD.

cbdMD latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.63 0.08  (112.65 %)2024 Q3
3/31/2024-0.77 -0.87  (-13.73 %)2024 Q2
12/31/2023-0.75 -0.67  (11.23 %)2024 Q1
9/30/2023-0.78 -1.21  (-56.09 %)2023 Q4
3/31/20230 -0.08  (0 %)2023 Q1
12/31/2021-1.84 -1.35  (26.47 %)2022 Q1
9/30/2021-0.05 -0.07  (-52.51 %)2021 Q4
6/30/2021-0.04 -0.01  (75.49 %)2021 Q3
3/31/2021-0.03 -0.24  (-684.31 %)2021 Q2
12/31/2020-0.02 -0.18  (-1,076.47 %)2021 Q1
1
2

Eulerpool ESG Scorecard© for the cbdMD stock

Eulerpool World ESG Rating (EESG©)

30/ 100

🌱 Environment

2

👫 Social

24

🏛️ Governance

64

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

cbdMD list of shareholders

%
Name
Stocks
Change
Date
0.59147 % Coffman (Raymond Scott)387,69513,0111/30/2024
0.21376 % Crc Investment Fund LP140,114140,1141/30/2024
0.14383 % Worldwide Media Services Group Inc94,27694,2762/1/2023
0.13914 % AXS Investments LLC91,20427,01712/31/2023
0.04777 % Renaissance Technologies LLC31,3114,40012/31/2023
0.03678 % Sentinus, LLC24,10624,1066/30/2023
0.03564 % Virtu Americas LLC23,36423,36412/31/2023
0.02627 % Susquehanna International Group, LLP17,21817,21812/31/2023
0.01990 % The Vanguard Group, Inc.13,042012/31/2023
0.01865 % Penserra Capital Management LLC12,227012/31/2023
1
2
3
4
5
...
9

cbdMD Executives and Management Board

Mr. T. Ronan Kennedy45
cbdMD Interim Chief Executive Officer, Chief Financial Officer
Compensation 275,000
Mr. William Raines64
cbdMD Independent Director
Compensation 67,945
Mr. Bakari Sellers39
cbdMD Independent Director
Compensation 60,820
Mr. Scott Stephen58
cbdMD Independent Chairman of the Board
Compensation 57,070
Dr. Sibyl Swift43
cbdMD Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director (since 2021)
Compensation 6,695
1
2

Most common questions regarding cbdMD

What values and corporate philosophy does cbdMD represent?

cbdMD Inc represents a strong set of values and corporate philosophy. The company is dedicated to providing high-quality CBD products that promote overall wellness. With a commitment to innovation, transparency, and excellence, cbdMD prioritizes the needs of its customers. The company's core values include quality, innovation, and accountability, ensuring that every product meets strict standards. As a leader in the CBD industry, cbdMD has built a reputation for integrity and trustworthiness, continuously pushing the boundaries of CBD manufacturing and setting new industry standards. With a customer-centric approach, cbdMD strives to enhance lives through the power of CBD.

In which countries and regions is cbdMD primarily present?

cbdMD Inc is primarily present in the United States. As a leading CBD company, cbdMD offers a wide range of premium hemp-derived products to customers across the nation. With its headquarters in North Carolina, cbdMD has established a strong presence in the US market, serving customers from all states. The company's expansion also includes online sales, making its products accessible to customers nationwide. cbdMD's commitment to quality and innovation has propelled its growth, positioning it as a trusted brand in the US CBD industry.

What significant milestones has the company cbdMD achieved?

cbdMD Inc has achieved several significant milestones since its inception. One notable achievement is the company's rapid growth and expansion. cbdMD Inc has successfully scaled its operations, becoming a leader in the CBD industry. Additionally, the company has gained recognition for its high-quality, THC-free CBD products, which have garnered a loyal customer base. cbdMD Inc has also secured various partnerships and collaborations, further solidifying its position in the market. With a commitment to innovation and customer satisfaction, the company continues to achieve new milestones and drive the growth of the CBD industry.

What is the history and background of the company cbdMD?

cbdMD Inc is a leading company in the CBD industry, specializing in the manufacturing and distribution of high-quality hemp-derived CBD products. Established in 2015, cbdMD has quickly gained recognition for its commitment to innovation and customer satisfaction. The company operates with a vertically integrated business model, controlling the entire production process from seed to shelf. cbdMD's extensive product line includes CBD oils, capsules, topicals, and pet products, catering to various consumer needs. With a strong dedication to quality and transparency, cbdMD has become a trusted name in the CBD market, offering customers safe and reliable CBD solutions.

Who are the main competitors of cbdMD in the market?

cbdMD Inc's main competitors in the market include Charlotte's Web Holdings Inc, Green Roads, and Curaleaf Holdings Inc.

In which industries is cbdMD primarily active?

cbdMD Inc is primarily active in the CBD (cannabidiol) industry. With a focus on producing high-quality CBD products, cbdMD Inc operates in various sectors, including health and wellness, supplements, and personal care. As a leading company in the CBD market, cbdMD Inc offers a wide range of CBD-infused products, such as oils, capsules, gummies, topicals, and pet products. cbdMD Inc's commitment to providing premium CBD solutions has positioned them as a reputable player in the CBD industry.

What is the business model of cbdMD?

cbdMD Inc's business model revolves around the manufacturing and distribution of a wide range of CBD-infused products. The company offers top-quality CBD oils, tinctures, capsules, gummies, skincare products, pet products, and much more. By leveraging their expertise in the extraction and production processes, cbdMD aims to provide customers with high-quality CBD products. The company also focuses on building a strong brand presence and engaging with their customers through various marketing channels. With a commitment to transparency and providing safe, THC-free products, cbdMD Inc has positioned itself as a reliable source for consumers seeking the potential health benefits of CBD.

What is the P/E ratio of cbdMD 2024?

The cbdMD P/E ratio is -0.01.

What is the P/S ratio of cbdMD 2024?

The cbdMD P/S ratio is 0.06.

What is the AlleAktien quality score of cbdMD?

The AlleAktien quality score for cbdMD is 1/10.

What is the revenue of cbdMD 2024?

The expected cbdMD revenue is 20.13 M USD.

How high is the profit of cbdMD 2024?

The expected cbdMD profit is -175.84 M USD.

What is the business model of cbdMD

cbdMD Inc is a company that was founded in 2015 and is based in Charlotte, North Carolina. The company focuses on the development and marketing of high-quality CBD products for the global market. cbdMD Inc offers a wide range of CBD products, including oils, capsules and gummies, vape oils, CBD skincare, CBD pet care, and CBD powder. The CBD oils offered by cbdMD Inc are available in different strengths, ranging from 300 mg to 7500 mg of CBD per bottle. The oils are made with MCT oil and do not contain any artificial colors or flavors. The capsules and gummies provide an easy way to consume CBD daily and are available in different concentrations. The company also offers medical formulas with added ingredients such as melatonin and L-theanine. The vape oil range includes various flavors and strengths, designed for use with suitable vaporizers. The CBD skincare products from cbdMD Inc are made with CBD isolate and are suitable for different skin types. These products do not contain parabens, sulfates, or artificial fragrances, making them suitable for sensitive skin. Pets can also benefit from cbdMD Inc's CBD knowledge and products. The company offers CBD pet care products for dogs, cats, and horses. These products contain a balanced blend of CBD oil and other nutrients to ensure optimal dosage and effectiveness. cbdMD Inc also provides CBD powder for athletes and individuals looking to incorporate it into their diet. The business model of cbdMD Inc is successful due to its focus on high-quality CBD products, fast shipping, and excellent customer support. The company operates an online platform for selling CBD products and has established extensive partnerships with retailers to distribute its products nationwide. cbdMD Inc also takes responsibility for the safety and purity of its products by actively using third-party labs for product verification. In summary, cbdMD Inc offers a wide range of CBD products suitable for customers with different needs and budgets. The company prioritizes high-quality products, fast shipping, and excellent customer support. Overall, the business model of cbdMD Inc is successful, and the company has gained a reputation as one of the leading CBD providers in the market.

What is the cbdMD dividend?

cbdMD pays a dividend of 0 USD distributed over payouts per year.

How often does cbdMD pay dividends?

The dividend cannot currently be calculated for cbdMD or the company does not pay out a dividend.

What is the cbdMD ISIN?

The ISIN of cbdMD is US12482W1018.

What is the cbdMD WKN?

The WKN of cbdMD is A2PJM3.

What is the cbdMD ticker?

The ticker of cbdMD is YCBD.

How much dividend does cbdMD pay?

Over the past 12 months, cbdMD paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, cbdMD is expected to pay a dividend of 0 USD.

What is the dividend yield of cbdMD?

The current dividend yield of cbdMD is .

When does cbdMD pay dividends?

cbdMD pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of cbdMD?

cbdMD paid dividends every year for the past 0 years.

What is the dividend of cbdMD?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is cbdMD located?

cbdMD is assigned to the 'Health' sector.

Wann musste ich die Aktien von cbdMD kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of cbdMD from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did cbdMD pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of cbdMD in the year 2023?

In the year 2023, cbdMD distributed 0 USD as dividends.

In which currency does cbdMD pay out the dividend?

The dividends of cbdMD are distributed in USD.

All fundamentals about cbdMD

Our stock analysis for cbdMD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of cbdMD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.